Development of a medium throughput whole-cell microtiter plate Thr286 autophosphorylation assay for CaMKIIα using ELISA

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Development of a medium throughput whole-cell microtiter plate Thr286 autophosphorylation assay for CaMKIIα using ELISA. / Palmelund, Line B.; van Woerden, Geeske M.; Bräuner-Osborne, Hans; Wellendorph, Petrine.

In: Journal of Pharmacological and Toxicological Methods, Vol. 118, 107226, 2022.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Palmelund, LB, van Woerden, GM, Bräuner-Osborne, H & Wellendorph, P 2022, 'Development of a medium throughput whole-cell microtiter plate Thr286 autophosphorylation assay for CaMKIIα using ELISA', Journal of Pharmacological and Toxicological Methods, vol. 118, 107226. https://doi.org/10.1016/j.vascn.2022.107226

APA

Palmelund, L. B., van Woerden, G. M., Bräuner-Osborne, H., & Wellendorph, P. (2022). Development of a medium throughput whole-cell microtiter plate Thr286 autophosphorylation assay for CaMKIIα using ELISA. Journal of Pharmacological and Toxicological Methods, 118, [107226]. https://doi.org/10.1016/j.vascn.2022.107226

Vancouver

Palmelund LB, van Woerden GM, Bräuner-Osborne H, Wellendorph P. Development of a medium throughput whole-cell microtiter plate Thr286 autophosphorylation assay for CaMKIIα using ELISA. Journal of Pharmacological and Toxicological Methods. 2022;118. 107226. https://doi.org/10.1016/j.vascn.2022.107226

Author

Palmelund, Line B. ; van Woerden, Geeske M. ; Bräuner-Osborne, Hans ; Wellendorph, Petrine. / Development of a medium throughput whole-cell microtiter plate Thr286 autophosphorylation assay for CaMKIIα using ELISA. In: Journal of Pharmacological and Toxicological Methods. 2022 ; Vol. 118.

Bibtex

@article{5a6eedfcb0b440b6941cfb8c08f058c0,
title = "Development of a medium throughput whole-cell microtiter plate Thr286 autophosphorylation assay for CaMKIIα using ELISA",
abstract = "Ca2+/calmodulin-dependent protein kinase II alpha (CaMKIIα) is a multifunctional Ser/Thr kinase involved in several neuronal signaling pathways including synaptic plasticity. CaMKIIα autonomous activity is highly dependent on Thr286 autophosphorylation (pThr286), which is widely used as a readout for its enzymatic activity. To readily characterise compounds and potential drug candidates targeting CaMKIIα, a simple, generic cell-based assay for quantification of pThr286 levels is needed. In this study, we present a cell-based assay using an adapted ELISA as a suitable and higher throughput alternative to Western blotting. In this 96-well plate-based assay, we use whole HEK293T cells recombinantly expressing CaMKIIα and apply a phospho-specific antibody to detect pThr286 levels by chemiluminescence. In parallel, total CaMKIIα expression levels are detected by fluorescence using an Alexa488-conjugated anti-myc antibody targeting a C-terminal myc-tag. By multiplexing chemiluminescence and fluorescence, phosphorylation levels are normalised to CaMKIIα total expression within each well. The specificity of the assay was confirmed using a phosphodead mutant (T286A) of CaMKIIα. By applying Ca2+ or known CaMKIIα inhibitors (KN93, tatCN21 and AS100105) and obtaining concentration-response curves, we demonstrate high sensitivity and validity of the assay. Lastly, we demonstrate the versatility of the assay by determining autophosphorylation levels in CaMKIIα patient-related mutations, known to possess altered pThr286 responses (E109D, E183V and H282R). The established assay for CaMKIIα is a reproducible, easily implemented, and facile ELISA-based assay that allows for reliable quantification of pThr286 levels.",
keywords = "Calcium/calmodulin-dependent protein kinase II, CaMKIIα patient-related mutations, Fluorescence, Luminescence, Methods, Multiplex detection, Pharmacological inhibitors, Stimulation",
author = "Palmelund, {Line B.} and {van Woerden}, {Geeske M.} and Hans Br{\"a}uner-Osborne and Petrine Wellendorph",
note = "Funding Information: This work was supported by the Independent Research Fund Denmark (Grant number 8020-00156B ), Simon Fougner Hartmann's Family Foundation and the Drug Research Academy . Publisher Copyright: {\textcopyright} 2022 The Authors",
year = "2022",
doi = "10.1016/j.vascn.2022.107226",
language = "English",
volume = "118",
journal = "Journal of Pharmacological and Toxicological Methods",
issn = "1056-8719",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Development of a medium throughput whole-cell microtiter plate Thr286 autophosphorylation assay for CaMKIIα using ELISA

AU - Palmelund, Line B.

AU - van Woerden, Geeske M.

AU - Bräuner-Osborne, Hans

AU - Wellendorph, Petrine

N1 - Funding Information: This work was supported by the Independent Research Fund Denmark (Grant number 8020-00156B ), Simon Fougner Hartmann's Family Foundation and the Drug Research Academy . Publisher Copyright: © 2022 The Authors

PY - 2022

Y1 - 2022

N2 - Ca2+/calmodulin-dependent protein kinase II alpha (CaMKIIα) is a multifunctional Ser/Thr kinase involved in several neuronal signaling pathways including synaptic plasticity. CaMKIIα autonomous activity is highly dependent on Thr286 autophosphorylation (pThr286), which is widely used as a readout for its enzymatic activity. To readily characterise compounds and potential drug candidates targeting CaMKIIα, a simple, generic cell-based assay for quantification of pThr286 levels is needed. In this study, we present a cell-based assay using an adapted ELISA as a suitable and higher throughput alternative to Western blotting. In this 96-well plate-based assay, we use whole HEK293T cells recombinantly expressing CaMKIIα and apply a phospho-specific antibody to detect pThr286 levels by chemiluminescence. In parallel, total CaMKIIα expression levels are detected by fluorescence using an Alexa488-conjugated anti-myc antibody targeting a C-terminal myc-tag. By multiplexing chemiluminescence and fluorescence, phosphorylation levels are normalised to CaMKIIα total expression within each well. The specificity of the assay was confirmed using a phosphodead mutant (T286A) of CaMKIIα. By applying Ca2+ or known CaMKIIα inhibitors (KN93, tatCN21 and AS100105) and obtaining concentration-response curves, we demonstrate high sensitivity and validity of the assay. Lastly, we demonstrate the versatility of the assay by determining autophosphorylation levels in CaMKIIα patient-related mutations, known to possess altered pThr286 responses (E109D, E183V and H282R). The established assay for CaMKIIα is a reproducible, easily implemented, and facile ELISA-based assay that allows for reliable quantification of pThr286 levels.

AB - Ca2+/calmodulin-dependent protein kinase II alpha (CaMKIIα) is a multifunctional Ser/Thr kinase involved in several neuronal signaling pathways including synaptic plasticity. CaMKIIα autonomous activity is highly dependent on Thr286 autophosphorylation (pThr286), which is widely used as a readout for its enzymatic activity. To readily characterise compounds and potential drug candidates targeting CaMKIIα, a simple, generic cell-based assay for quantification of pThr286 levels is needed. In this study, we present a cell-based assay using an adapted ELISA as a suitable and higher throughput alternative to Western blotting. In this 96-well plate-based assay, we use whole HEK293T cells recombinantly expressing CaMKIIα and apply a phospho-specific antibody to detect pThr286 levels by chemiluminescence. In parallel, total CaMKIIα expression levels are detected by fluorescence using an Alexa488-conjugated anti-myc antibody targeting a C-terminal myc-tag. By multiplexing chemiluminescence and fluorescence, phosphorylation levels are normalised to CaMKIIα total expression within each well. The specificity of the assay was confirmed using a phosphodead mutant (T286A) of CaMKIIα. By applying Ca2+ or known CaMKIIα inhibitors (KN93, tatCN21 and AS100105) and obtaining concentration-response curves, we demonstrate high sensitivity and validity of the assay. Lastly, we demonstrate the versatility of the assay by determining autophosphorylation levels in CaMKIIα patient-related mutations, known to possess altered pThr286 responses (E109D, E183V and H282R). The established assay for CaMKIIα is a reproducible, easily implemented, and facile ELISA-based assay that allows for reliable quantification of pThr286 levels.

KW - Calcium/calmodulin-dependent protein kinase II

KW - CaMKIIα patient-related mutations

KW - Fluorescence

KW - Luminescence

KW - Methods

KW - Multiplex detection

KW - Pharmacological inhibitors

KW - Stimulation

U2 - 10.1016/j.vascn.2022.107226

DO - 10.1016/j.vascn.2022.107226

M3 - Journal article

C2 - 36174932

AN - SCOPUS:85139083185

VL - 118

JO - Journal of Pharmacological and Toxicological Methods

JF - Journal of Pharmacological and Toxicological Methods

SN - 1056-8719

M1 - 107226

ER -

ID: 322283123